In this context, our study sought to investigate the prognostication capability of a 22‐gene mutational profile obtained through targeted sequencing in women with ER+/ERBB2‐ EBC, whose primary breast cancer specimens were retrievable from a tissue bank. The gene discussed is ESR1; the disease is breast carcinoma.